Announced
Completed
Synopsis
GTCR-backed Maravai LifeSciences, a biotechnology production equipment provider, completed the acquisition of MockV Solutions, an American biotechnology company. Financial terms were not disclosed. “The acquisition supports our commitment to the bioprocess impurity testing market, which we first entered with the acquisition of Cygnus Technologies, and extends our offerings to viral clearance, further enabling the manufacture of safe biotherapeutics,” Eric Tardif, Maravai President.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.